Hepatic Encephalopathy Grading: West Haven Criteria to Child-Pugh Score

Standardize neuropsychiatric assessment using the West Haven grading criteria and map grades directly into Child-Pugh score points with differential diagnosis and treatment guidelines.

Hepatic encephalopathy (HE) is a spectrum of reversible neuropsychiatric and cognitive disturbances observed in patients with chronic liver disease, cirrhosis, and portosystemic shunts. Ranging from subtle alterations in sleep architecture and psychomotor speed to marked lethargy, asterixis, and fatal hepatic coma, encephalopathy reflects severe functional parenchymal loss and hemodynamic shunting of gut-derived nitrogenous toxins. In the child pugh score calculator, hepatic encephalopathy contributes 1, 2, or 3 points based on the standardized West Haven Criteria. This clinical guide assists clinicians in accurately identifying and grading encephalopathy while diagnosing underlying precipitating triggers and instituting evidence-based therapies.

Pathophysiology: Ammonia, Neurotoxins, and Astrocytic Swelling

The central pathophysiological mediator of hepatic encephalopathy is ammonia (NH3). Enterocytes and colonic bacterial flora generate ammonia via the deamination of glutamine and bacterial urease catabolism of dietary proteins. In healthy individuals, portal blood transports ammonia directly to the liver, where periportal hepatocytes convert it to water-soluble urea via the Krebs-Henseleit urea cycle, while perivenous hepatocytes synthesize glutamine.

In cirrhosis, structural hepatic damage diminishes urea cycle enzymatic capacity, while spontaneous portosystemic collaterals (and surgical or transjugular intrahepatic portosystemic shunts [TIPS]) allow portal blood to bypass the liver entirely. Systemic arterial hyperammonemia crosses the blood-brain barrier. In cerebral astrocytes, the enzyme glutamine synthetase metabolizes ammonia and glutamate into glutamine. Intracellular accumulation of glutamine exerts potent osmotic effects, inducing astrocyte swelling, low-grade cerebral edema, oxidative stress, and impaired neurotransmission (GABAergic and glutamatergic signaling).

West Haven Criteria and Child-Pugh Point Assignment

The child pugh classification utilizes the West Haven Criteria to assign points:

• Grade 0 (None) = 1 Point: Normal mentation. No clinical or neuropsychiatric abnormalities detectable on standard physical exam (subclinical covert encephalopathy requires psychometric testing).

• Grade 1 or 2 (Mild) = 2 Points:

– West Haven Grade 1: Trivial lack of awareness, shortened attention span, mild euphoria or anxiety, altered sleep-wake rhythm (daytime somnolence and nighttime insomnia), mild cognitive slowing.

– West Haven Grade 2: Lethargy or apathy, disorientation for time, demonstrable personality changes, inappropriate behavior, and demonstrable asterixis (flapping tremor of dorsiflexed wrists).

• Grade 3 or 4 (Severe) = 3 Points:

– West Haven Grade 3: Somnolence to semi-stupor, gross disorientation for time and space, confusion, bizarre behavior, yet responsive to verbal or noxious stimuli. Asterixis usually present if cooperative.

– West Haven Grade 4: Hepatic coma. Completely unresponsive to verbal commands; decerebrate or decorticate posturing may occur; asterixis absent.

Identifying and Treating Precipitating Factors

Hepatic encephalopathy rarely develops spontaneously; in over 85% of cases, it is unmasked by an acute clinical trigger. Routine clinical evaluation must systematically investigate:

1. Infections: Spontaneous bacterial peritonitis (SBP), urinary tract infection (UTI), pneumonia, or bacteremia.

2. Gastrointestinal Hemorrhage: Upper GI bleeding from varices provides a massive protein load (blood in the lumen) that gut bacteria convert into ammonia.

3. Electrolyte Derangements and Dehydration: Over-diuresis, hypokalemia, and metabolic alkalosis promote renal ammonia generation and crossing of the blood-brain barrier.

4. Constipation: Prolonged colonic transit time increases bacterial ammonia absorption.

5. Sedative Medications: Inappropriate administration of benzodiazepines, opioids, or hypnotics.

First-line medical therapy centers on non-absorbable disaccharides (lactulose, titrated to 2–3 soft bowel movements daily) and non-absorbable antibiotics (rifaximin 550 mg twice daily).

Differential Diagnosis and Monitoring Guidance

When a cirrhotic patient presents with acute cognitive decline, encephalopathy is a clinical diagnosis of exclusion. Clinicians must rule out alternative causes of delirium, including intracranial hemorrhage (subdural hematoma is common due to falls and coagulopathy), non-convulsive status epilepticus, acute alcohol withdrawal (delirium tremens), severe hypoglycemia, and medication toxicity. Routine venous ammonia levels do not correlate with clinical severity or recovery and should not be followed serially.

Clinical takeaways

  • Grade 0 (none) = 1 pt; Grade 1–2 (mild confusion, asterixis) = 2 pts; Grade 3–4 (somnolence, coma) = 3 pts.
  • Lactulose (2–3 bowel movements/day) and rifaximin (550 mg BID) are first-line therapies.
  • Always search for and treat underlying triggers (infection, GI bleed, constipation, sedatives).
  • Avoid serial blood ammonia measurements; rely on mental status examination.

Limitations

  • Inter-examiner variability in distinguishing West Haven Grade 1 from Grade 2.
  • Routine venous ammonia levels correlate poorly with clinical severity and should not be used to titrate treatment.
  • Always rule out intracranial hemorrhage, stroke, sepsis, and hypoglycemia before diagnosing hepatic coma.

References

  1. Pugh RN, et al. Br J Surg. 1973;60(8):646-649.
  2. Vilstrup H, et al. Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by AASLD and EASL. Hepatology. 2014;60(2):715-735.